Skip to main content
. 2019 Nov 4;74:e1316. doi: 10.6061/clinics/2019/e1316

Table 2. Assessment of the quality and risk of bias of 19 selected systematic reviews of treatments for anxiety disorders, in accordance with the A MeaSurement Tool to Assess systematic Reviews (AMSTAR 2.0) and Risk Of Bias In Systematic reviews (ROBIS).

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 AMSTAR ROBIS
Author PICO Protocol Study selection Literature search Selection in duplicate Extraction in duplicate Excluded studies Included studies Individual risk of bias Funding of studies Appropriate meta-analysis Impact of risk of bias Interpreting/ discussing results Discussion of heterogeneity Publication bias Conflict of interest Quality Risk of bias
Nonbiological or psychological treatments
Mayo-Wilson, 2013 (25) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic High Low
Jayakody, 2014 (22) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic NA NA Inline graphic Inline graphic NA Inline graphic Low Uncertain
Arnberg, 2014 (26) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Moderate Low
Abbass, 2014 (27) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic High Low
Norton, 2015 (23) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic NA NA Inline graphic Inline graphic NA Inline graphic Moderate Uncertain
Olthuis, 2015 (28) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic High Low
Wu, 2015 (30) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic High Low
Newby, 2015 (29) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphicRCTInline graphicNRCT Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Low Uncertain
Piccirillo, 2016 (24) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic NA NA Inline graphic Inline graphic NA Inline graphic Critical low High
Stubbs, 2017 (31) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Moderate Low
Cramer, 2018 (32) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Low Uncertain
Biological or pharmacological treatments
Li, 2014 (33) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic High Low
Patterson, 2016 (34) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Low Uncertain
Williams, 2017 (35) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic High Low
Sugarman, 2017 (36) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Critical low High
Yee, 2018 (37) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Critical low High
Multimodal combinedtreatment comparisons
Bandelow, 2015 (15) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Low Uncertain
Ho, 2016 (38) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Low Uncertain
Bandelow, 2018 (14) Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Inline graphic Low Uncertain

Footnotes:

Inline graphicYes

Inline graphicNo

Inline graphicPartial Yes

NA: not applicable - no meta-analysis.

RCT/NRCT: randomized controlled trials/nonrandomized controlled trials.